000 | 01742 a2200505 4500 | ||
---|---|---|---|
005 | 20250516115818.0 | ||
264 | 0 | _c20130114 | |
008 | 201301s 0 0 eng d | ||
022 | _a1939-327X | ||
024 | 7 |
_a10.2337/db11-1655 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSivaskandarajah, Gavasker A | |
245 | 0 | 0 |
_aVegfa protects the glomerular microvasculature in diabetes. _h[electronic resource] |
260 |
_bDiabetes _cNov 2012 |
||
300 |
_a2958-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 |
_aDiabetic Nephropathies _xmetabolism |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xetiology |
650 | 0 | 4 |
_aKidney Glomerulus _xblood supply |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMicrovessels _xmetabolism |
650 | 0 | 4 |
_aPodocytes _xmetabolism |
650 | 0 | 4 |
_aProteinuria _xetiology |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
700 | 1 | _aJeansson, Marie | |
700 | 1 | _aMaezawa, Yoshiro | |
700 | 1 | _aEremina, Vera | |
700 | 1 | _aBaelde, Hans J | |
700 | 1 | _aQuaggin, Susan E | |
773 | 0 |
_tDiabetes _gvol. 61 _gno. 11 _gp. 2958-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/db11-1655 _zAvailable from publisher's website |
999 |
_c22208564 _d22208564 |